These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34449715)

  • 21. Guillain-Barré syndrome after coronavirus disease 2019 vaccine: A temporal association.
    da Silva GF; da Silva CF; Oliveira RENDN; Romancini F; Mendes RM; Locks A; Longo MFM; Moro CHC; Longo AL; Braatz VL
    Clin Exp Neuroimmunol; 2022 May; 13(2):92-94. PubMed ID: 34900000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation.
    Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M
    J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Guillain-Barré syndrome variant with prominent facial diplegia.
    Susuki K; Koga M; Hirata K; Isogai E; Yuki N
    J Neurol; 2009 Nov; 256(11):1899-905. PubMed ID: 19633904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.
    Finsterer J
    IDCases; 2021; 25():e01226. PubMed ID: 34290962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
    Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
    BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report.
    Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D
    Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
    Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
    Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.
    Razok A; Shams A; Almeer A; Zahid M
    Ann Med Surg (Lond); 2021 Jul; 67():102540. PubMed ID: 34249353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.
    Tamborska AA; Singh B; Leonhard SE; Hodel EM; Stowe J; Watson-Fargie T; Fernandes PM; Themistocleous AC; Roelofs J; Brennan K; Morrice C; Michael BD; Jacobs BC; McDonald H; Solomon T;
    BMJ Neurol Open; 2022; 4(2):e000309. PubMed ID: 35856053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guillain-Barré syndrome after COVID-19 vaccination.
    McKean N; Chircop C
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation.
    Rane RP; Jain A; Hussain KM; Naik S; Shahab A
    Cureus; 2022 Jun; 14(6):e25810. PubMed ID: 35720780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: Guillain-Barré Syndrome Associated With COVID-19.
    Khedr EM; Shoyb A; Mohamed KO; Karim AA; Saber M
    Front Neurol; 2021; 12():678136. PubMed ID: 34239495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
    Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
    J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases.
    Kim JE; Min YG; Shin JY; Kwon YN; Bae JS; Sung JJ; Hong YH
    Front Neurol; 2021; 12():820723. PubMed ID: 35153993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late-Onset Guillain-Barré Syndrome and Right Facial Nerve Palsy after COVID-19 Infection.
    Taguchi M; Bonner K; Memon AB
    Case Rep Neurol; 2022; 14(1):12-18. PubMed ID: 35111031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.